2020 Q3 Form 10-Q Financial Statement

#000149315220015834 Filed on August 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $362.2K $472.1K $842.1K
YoY Change 6.52% -43.93% 471.9%
Cost Of Revenue $185.3K $250.8K $64.21K
YoY Change 393.69% 290.66% 105.94%
Gross Profit $176.9K $221.3K $777.9K
YoY Change -41.52% -71.55% 639.55%
Gross Profit Margin 48.84% 46.87% 92.38%
Selling, General & Admin $51.46K $17.73K $46.54K
YoY Change -11.95% -61.91% -36.97%
% of Gross Profit 29.09% 8.01% 5.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.190K $9.070K $11.33K
YoY Change 9.36% -19.95% -43.35%
% of Gross Profit 3.5% 4.1% 1.46%
Operating Expenses $240.0K $296.1K $365.6K
YoY Change 4.44% -19.02% 3.48%
Operating Profit -$63.09K -$74.75K $412.3K
YoY Change -186.75% -118.13% -266.15%
Interest Expense $66.20K $6.230K -$41.56K
YoY Change -120.11% -114.99% -205.73%
% of Operating Profit -10.08%
Other Income/Expense, Net $66.20K $98.01K -$41.56K
YoY Change -120.11% -335.83% -90.41%
Pretax Income $3.110K $23.26K $370.7K
YoY Change -101.21% -93.73% -154.52%
Income Tax
% Of Pretax Income
Net Earnings $3.108K $23.26K $370.7K
YoY Change -101.21% -93.73% -154.39%
Net Earnings / Revenue 0.86% 4.93% 44.02%
Basic Earnings Per Share
Diluted Earnings Per Share $24.04 $236.80 $4.428K
COMMON SHARES
Basic Shares Outstanding 128.6M shares 91.85M shares 82.86M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $232.0K $254.9K $823.4K
YoY Change 20.18% -69.04% 1076.21%
Cash & Equivalents $227.4K $249.4K $188.5K
Short-Term Investments $4.600K $5.490K $634.9K
Other Short-Term Assets $88.88K $143.2K $13.58K
YoY Change 746.5% 954.68% -68.12%
Inventory $98.73K $220.4K $42.03K
Prepaid Expenses
Receivables $70.63K $38.96K $104.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $490.3K $657.5K $983.4K
YoY Change 50.53% -33.13% 272.82%
LONG-TERM ASSETS
Property, Plant & Equipment $9.065K $10.25K $29.09K
YoY Change -61.83% -64.76% -69.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $14.07K $20.25K $44.72K
YoY Change -63.99% -54.72% -60.86%
TOTAL ASSETS
Total Short-Term Assets $490.3K $657.5K $983.4K
Total Long-Term Assets $14.07K $20.25K $44.72K
Total Assets $504.3K $677.8K $1.028M
YoY Change 38.27% -34.07% 171.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $187.4K $201.3K $229.0K
YoY Change -6.78% -12.08% -20.76%
Accrued Expenses $314.6K $330.6K $417.9K
YoY Change -25.43% -20.89% -4.41%
Deferred Revenue $38.45K $41.65K $325.0K
YoY Change -75.21% -87.18%
Short-Term Debt $1.820M $1.990M $2.448M
YoY Change -23.72% -18.7% 1123.78%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.178M $3.457M $4.224M
YoY Change -15.77% -18.15% 30.44%
LONG-TERM LIABILITIES
Long-Term Debt $217.9K $227.9K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $217.9K $227.9K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.178M $3.457M $4.224M
Total Long-Term Liabilities $217.9K $227.9K $0.00
Total Liabilities $3.396M $3.685M $4.224M
YoY Change -9.99% -12.76% 30.44%
SHAREHOLDERS EQUITY
Retained Earnings -$23.78M -$23.78M -$23.01M
YoY Change 2.2% 3.35% 4.06%
Common Stock $13.49K $11.24K $8.688K
YoY Change 126.27% 29.32% -99.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.892M -$3.007M -$3.195M
YoY Change
Total Liabilities & Shareholders Equity $504.3K $677.8K $1.028M
YoY Change 38.27% -34.07% 171.96%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $3.108K $23.26K $370.7K
YoY Change -101.21% -93.73% -154.39%
Depreciation, Depletion And Amortization $6.190K $9.070K $11.33K
YoY Change 9.36% -19.95% -43.35%
Cash From Operating Activities $18.20K -$268.5K $155.8K
YoY Change -121.16% -272.4% -255.77%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.21K 420.6K 3.010K
YoY Change 53.12% 13872.76% -98.12%
NET CHANGE
Cash From Operating Activities 18.20K -268.5K 155.8K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities -40.21K 420.6K 3.010K
Net Change In Cash -22.01K 152.0K 158.8K
YoY Change -80.4% -4.25% 217.56%
FREE CASH FLOW
Cash From Operating Activities $18.20K -$268.5K $155.8K
Capital Expenditures $0.00
Free Cash Flow $155.8K
YoY Change -273.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2071000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2071000000 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
20024 usd
CY2020Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2019Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
133078 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
90888 usd
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-3006855 usd
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-3597538 usd
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-3195472 usd
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-3449628 usd
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-3723960 usd
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-3486887 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001375793
us-gaap Net Income Loss
NetIncomeLoss
30170 usd
us-gaap Net Income Loss
NetIncomeLoss
-185749 usd
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
23262 usd
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
370726 usd
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
112352119 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71419795 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112352119 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71419795 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-434219 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53134 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
93094 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
244484 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-86358 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-38185 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
132864 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10103 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
184213 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19463 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8856 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6820 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
20024 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
412251 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
65510 usd
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
249433 usd
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125200 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
9219 usd
us-gaap Interest Paid Net
InterestPaidNet
11764 usd
dei Entity Registrant Name
EntityRegistrantName
GTX CORP
CY2019Q4 us-gaap Inventory Net
InventoryNet
36192 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
157600 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
76880 usd
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
134000 usd
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
677794 usd
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
312221 usd
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23779349 usd
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23559519 usd
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20761158 usd
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19954738 usd
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
11235 usd
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
7142 usd
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3456779 usd
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3909759 usd
CY2020Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
70950 usd
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
223536 usd
CY2020Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
884546 usd
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
884546 usd
CY2020Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
889820 usd
CY2019Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1099278 usd
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
330646 usd
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
441082 usd
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
201323 usd
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
203126 usd
CY2020Q2 us-gaap Assets
Assets
677794 usd
CY2019Q4 us-gaap Assets
Assets
312221 usd
CY2020Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
10000 usd
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
15000 usd
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10253 usd
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18404 usd
CY2020Q2 us-gaap Assets Current
AssetsCurrent
657541 usd
CY2019Q4 us-gaap Assets Current
AssetsCurrent
278817 usd
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
143247 usd
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
10383 usd
CY2020Q2 us-gaap Inventory Net
InventoryNet
220405 usd
CY2020Q2 us-gaap Notes Payable Current
NotesPayableCurrent
215381 usd
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
308000 usd
CY2020Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
38962 usd
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
47818 usd
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87133416 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
77554574 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
98222706 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
83730416 shares
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
325125 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-180496 usd
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
98008 usd
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41559 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-294955 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5253 usd
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-74746 usd
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
412285 usd
us-gaap Operating Expenses
OperatingExpenses
578341 usd
us-gaap Operating Expenses
OperatingExpenses
846145 usd
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
296054 usd
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
365611 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80026 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
124112 usd
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11340 usd
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44683 usd
us-gaap Professional Fees
ProfessionalFees
161081 usd
us-gaap Professional Fees
ProfessionalFees
355231 usd
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
115140 usd
CY2019Q2 us-gaap Professional Fees
ProfessionalFees
138817 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13149 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3420 usd
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6389 usd
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1857 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
324085 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
363382 usd
CY2020Q2 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
163185 usd
CY2019Q2 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
180254 usd
us-gaap Gross Profit
GrossProfit
283386 usd
us-gaap Gross Profit
GrossProfit
840892 usd
CY2020Q2 us-gaap Gross Profit
GrossProfit
221308 usd
CY2019Q2 us-gaap Gross Profit
GrossProfit
777896 usd
CY2020Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
822463 usd
CY2019Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
680119 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-28422 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
299000 usd
GTXO Interest Expense And Financing Costs
InterestExpenseAndFinancingCosts
49193 usd
GTXO Interest Expense And Financing Costs
InterestExpenseAndFinancingCosts
154467 usd
CY2020Q2 GTXO Interest Expense And Financing Costs
InterestExpenseAndFinancingCosts
8372 usd
CY2019Q2 GTXO Interest Expense And Financing Costs
InterestExpenseAndFinancingCosts
78571 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
13151 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
29924 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
568863 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
945011 usd
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
472147 usd
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
842105 usd
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41650 usd
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
70072 usd
dei Amendment Flag
AmendmentFlag
false
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5494 usd
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
59224 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
124233 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
118644 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
249433 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
125200 usd
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
188500 usd
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
69856 usd
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
285477 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104119 usd
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
250839 usd
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
64209 usd
GTXO Loss On Marketable Securities
LossOnMarketableSecurities
92471 usd
GTXO Loss On Marketable Securities
LossOnMarketableSecurities
506 usd
CY2020Q2 GTXO Loss On Marketable Securities
LossOnMarketableSecurities
598 usd
CY2019Q2 GTXO Loss On Marketable Securities
LossOnMarketableSecurities
usd
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
dei Entity Small Business
EntitySmallBusiness
true
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 integer
CY2019 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
10889 shares
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
603 usd
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
690 usd
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
219802 usd
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35502 usd
us-gaap Depreciation
Depreciation
8151 usd
us-gaap Depreciation
Depreciation
29924 usd
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
403760 usd
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
395609 usd
CY2020Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
889820 usd
CY2019Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1099278 usd
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
152586 usd
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
55750000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
36000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
20250000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
500000 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-129261 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
GTXO Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
0.04
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-92471 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-634506 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
152586 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4739 usd
CY2020Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
14000 usd
CY2019Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
37012 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-219830 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-185749 usd
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-76738 usd
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
370726 usd
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
100000 usd
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
usd
CY2020Q2 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
100000 usd
CY2019Q2 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
usd
GTXO Interest Added To Convertible Note Balance
InterestAddedToConvertibleNoteBalance
49250 usd
GTXO Interest Added To Convertible Note Balance
InterestAddedToConvertibleNoteBalance
64342 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
250000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
214841079 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
123188177 shares
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
139319 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
71510 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
204938 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6000 usd
CY2020Q2 GTXO Working Capital Defecit
WorkingCapitalDefecit
2799238 usd
CY2020Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
5494 usd
CY2019Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
59224 usd
CY2020Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
586738 usd
CY2019Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
458131 usd
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
128601415 shares
GTXO Gain On Conversion Of Convertible Notes
GainOnConversionOfConvertibleNotes
129261 usd
GTXO Gain On Conversion Of Convertible Notes
GainOnConversionOfConvertibleNotes
-11250 usd
CY2020Q2 GTXO Gain On Conversion Of Convertible Notes
GainOnConversionOfConvertibleNotes
91782 usd
CY2019Q2 GTXO Gain On Conversion Of Convertible Notes
GainOnConversionOfConvertibleNotes
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
146201 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
146201 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
133078 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
91887 usd
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
110956 usd
CY2019Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
39742 usd
GTXO Stock Issuance Of Preferred Stock For Financings
StockIssuanceOfPreferredStockForFinancings
250000 usd
GTXO Stock Issuance Of Preferred Stock For Financings
StockIssuanceOfPreferredStockForFinancings
3100 usd
CY2020Q2 GTXO Stock Issuance Of Preferred Stock For Financings
StockIssuanceOfPreferredStockForFinancings
200000 usd
CY2019Q2 GTXO Stock Issuance Of Preferred Stock For Financings
StockIssuanceOfPreferredStockForFinancings
27500 usd
GTXO Stock Issuance Of Warrants For Financings
StockIssuanceOfWarrantsForFinancings
3793 usd
GTXO Stock Issuance Of Warrants For Financings
StockIssuanceOfWarrantsForFinancings
49992 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4799 usd
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3793 usd
us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
213247 usd
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
90521 usd
GTXO Retention Bonus
RetentionBonus
16042 usd
CY2020Q2 GTXO Retention Bonus
RetentionBonus
8021 usd
GTXO Deemed Dividend
DeemedDividend
usd
CY2020Q2 GTXO Adjustments To Additional Paid In Capital Deemed Dividend On Fair Value Of Warrants And Conversion Feature Associated With Preferred Stock
AdjustmentsToAdditionalPaidInCapitalDeemedDividendOnFairValueOfWarrantsAndConversionFeatureAssociatedWithPreferredStock
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3793 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
GTXO Debt Discount Related To Derivative Liabilities
DebtDiscountRelatedToDerivativeLiabilities
usd
GTXO Debt Discount Related To Derivative Liabilities
DebtDiscountRelatedToDerivativeLiabilities
20024 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
227870 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
usd
CY2019Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
22222 shares
CY2019Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
to a 1:45 stock split
CY2019Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
634000 usd
GTXO Stock Issued For Remaining Shares
StockIssuedForRemainingShares
2833 shares
GTXO Stock Issued For Remaining
StockIssuedForRemaining
4551 usd
GTXO Loss From Change In Fair Value Investment
LossFromChangeInFairValueInvestment
10640 usd
us-gaap Principal Investment Gains Losses
PrincipalInvestmentGainsLosses
91780 usd
GTXO Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
CY2020Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
227870 usd
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
usd
CY2020Q2 us-gaap Liabilities
Liabilities
3684649 usd
CY2019Q4 us-gaap Liabilities
Liabilities
3909759 usd
GTXO Redeemable Preferred Stock Dividends One
RedeemablePreferredStockDividendsOne
-150000 usd
GTXO Redeemable Preferred Stock Dividends One
RedeemablePreferredStockDividendsOne
usd
CY2020Q2 GTXO Redeemable Preferred Stock Dividends One
RedeemablePreferredStockDividendsOne
usd
CY2019Q2 GTXO Redeemable Preferred Stock Dividends One
RedeemablePreferredStockDividendsOne
usd
GTXO Fair Value Of Retention Bonus Shares
FairValueOfRetentionBonusShares
16042 usd
GTXO Fair Value Of Retention Bonus Shares
FairValueOfRetentionBonusShares
213247 usd
GTXO Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
157600 usd
GTXO Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
81679 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Use of Estimates</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the accompanying unaudited financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-term asset valuation, warranty and other obligations and commitments. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Concentrations</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently rely on one manufacturer to supply us with our GPS SmartSole and one manufacturer to supply us with the GPS device included in the GPS SmartSole. The loss of either of these manufacturers could severely impede our ability to manufacture the GPS SmartSole.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the six months ended June 30, 2020, the Company had three customers representing approximately 30%, 28% and 14% of sales, respectively, and four customers representing approximately 21%, 16%, 10% and 10% of total accounts receivable, respectively, as of the period then ended. The Company had two customers representing approximately 82%, and 6% of sales, respectively, for the six months ended June 30, 2019, and three customers representing approximately 37%, 23%, and 12% of total accounts receivable, respectively, as of the period then ended.</p>

Files In Submission

Name View Source Status
0001493152-20-015834-index-headers.html Edgar Link pending
0001493152-20-015834-index.html Edgar Link pending
0001493152-20-015834.txt Edgar Link pending
0001493152-20-015834-xbrl.zip Edgar Link pending
ex10-1.htm Edgar Link pending
ex10-1_001.jpg Edgar Link pending
ex10-2.htm Edgar Link pending
ex10-2_001.jpg Edgar Link pending
ex10-2_002.jpg Edgar Link pending
ex10-2_003.jpg Edgar Link pending
ex10-2_004.jpg Edgar Link pending
ex10-2_005.jpg Edgar Link pending
ex10-2_006.jpg Edgar Link pending
ex10-2_007.jpg Edgar Link pending
ex10-2_008.jpg Edgar Link pending
ex10-2_009.jpg Edgar Link pending
ex10-2_010.jpg Edgar Link pending
ex10-2_011.jpg Edgar Link pending
ex10-2_012.jpg Edgar Link pending
ex10-2_013.jpg Edgar Link pending
ex10-2_014.jpg Edgar Link pending
ex10-2_015.jpg Edgar Link pending
ex10-2_016.jpg Edgar Link pending
ex10-2_017.jpg Edgar Link pending
ex10-2_018.jpg Edgar Link pending
ex10-2_019.jpg Edgar Link pending
ex10-2_020.jpg Edgar Link pending
ex10-2_021.jpg Edgar Link pending
ex10-2_022.jpg Edgar Link pending
ex10-2_023.jpg Edgar Link pending
ex10-2_024.jpg Edgar Link pending
ex10-2_025.jpg Edgar Link pending
ex10-2_026.jpg Edgar Link pending
ex10-2_027.jpg Edgar Link pending
ex10-2_028.jpg Edgar Link pending
ex10-3.htm Edgar Link pending
ex10-3_001.jpg Edgar Link pending
ex10-3_002.jpg Edgar Link pending
ex10-3_003.jpg Edgar Link pending
ex10-3_004.jpg Edgar Link pending
ex10-3_005.jpg Edgar Link pending
ex10-3_006.jpg Edgar Link pending
ex10-3_007.jpg Edgar Link pending
ex10-3_008.jpg Edgar Link pending
ex10-3_009.jpg Edgar Link pending
ex10-3_010.jpg Edgar Link pending
ex10-3_011.jpg Edgar Link pending
ex10-3_012.jpg Edgar Link pending
ex10-3_013.jpg Edgar Link pending
ex10-3_014.jpg Edgar Link pending
ex10-3_015.jpg Edgar Link pending
ex10-3_016.jpg Edgar Link pending
ex10-3_017.jpg Edgar Link pending
ex10-3_018.jpg Edgar Link pending
ex10-3_019.jpg Edgar Link pending
ex10-3_020.jpg Edgar Link pending
ex10-3_021.jpg Edgar Link pending
ex10-3_022.jpg Edgar Link pending
ex10-3_023.jpg Edgar Link pending
ex10-3_024.jpg Edgar Link pending
ex10-3_025.jpg Edgar Link pending
ex10-3_026.jpg Edgar Link pending
ex10-3_027.jpg Edgar Link pending
ex10-3_028.jpg Edgar Link pending
ex10-4.htm Edgar Link pending
ex10-4_001.jpg Edgar Link pending
ex10-4_002.jpg Edgar Link pending
ex10-4_003.jpg Edgar Link pending
ex10-4_004.jpg Edgar Link pending
ex10-4_005.jpg Edgar Link pending
ex10-4_006.jpg Edgar Link pending
ex10-4_007.jpg Edgar Link pending
ex10-4_008.jpg Edgar Link pending
ex10-4_009.jpg Edgar Link pending
ex10-4_010.jpg Edgar Link pending
ex10-4_011.jpg Edgar Link pending
ex10-4_012.jpg Edgar Link pending
ex10-4_013.jpg Edgar Link pending
ex10-4_014.jpg Edgar Link pending
ex10-4_015.jpg Edgar Link pending
ex10-4_016.jpg Edgar Link pending
ex10-4_017.jpg Edgar Link pending
ex10-4_018.jpg Edgar Link pending
ex10-4_019.jpg Edgar Link pending
ex10-5.htm Edgar Link pending
ex10-5_001.jpg Edgar Link pending
ex10-5_002.jpg Edgar Link pending
ex10-5_003.jpg Edgar Link pending
ex10-5_004.jpg Edgar Link pending
ex10-5_005.jpg Edgar Link pending
ex10-5_006.jpg Edgar Link pending
ex10-5_007.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
gtxo-20200630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
gtxo-20200630_cal.xml Edgar Link unprocessable
gtxo-20200630_def.xml Edgar Link unprocessable
gtxo-20200630_pre.xml Edgar Link unprocessable
gtxo-20200630.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gtxo-20200630_lab.xml Edgar Link unprocessable